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INNOVATION 
GOVERNANCE: 
How proactive is your board?
EXECUTIVE BRIEF
All global business and technology 
trends point in the same direction: there 
is a need for more proactive and far- 
sighted management of innovation. 
Innovation for business reinforcement 
and g row th, and transformation in 
particular, are, of course, the prime 
responsibilit y of top mana gement. 
In novat ion gover na nce –a hol ist ic 
approach to steering, promoting and 
sustaining innovation–is thus becoming 
a new management imperative. 
Boards of directors, too, need to be 
more than just observers of this renewed 
management interest in innovation, 
because so much is at stake. In a growing 
number of industries and companies, 
innovation will determine future success 
or failure. Of course, boards do not need 
to interfere with company leaders in the 
day-to-day management of innovation, but 
they should include a strong innovation 
element in their traditional corporate 
governance missions, that is: strategy 
review, auditing, performance review, 
risk prevention and, last but not least, 
CEO nomination. 
It is therefore a healthy practice 
for boards to regularly ref lect on the 
following questions:
• To what extent is innovation, broadly 
defined, an agenda item in our board 
meetings?
• What role, if any, should our board 
play vis-à-vis management regarding 
innovation?
To facilitate their self-assessment, 
boards should answer a number of 
practical questions that represent good 
practice in the governance of innovation. 
I have put the following ten questions 
across to several board members, and 
Innovation governance– 
a holistic approach  
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Ten good board 
practices on innovation. 
By Jean-Philippe Deschamps
1.  Have we set an innovation 
agenda in many, if not most,  
of our meetings?
Board meetings are always crowded 
with all kinds of statutory corporate 
governance questions, without talking 
about the need to handle unexpected 
events and crises. So, unless innovation 
issues are inserted into the board 
agenda, they would not be covered. It is 
a good practice to include innovation as 
a regular and open agenda item in at 
least a couple of board meetings per 
year. It should also be a key item in the 
annual strategy retreat that many boards 
set up with the top management team. 
Many of the following questions will 
provide a focus for this open innovation 
agenda item.
2.  Do we regularly review  
‘make-or-break’ innovation 
projects?
In some industries, like pharmaceuticals, 
automotive, energ y and aerospace, 
company boards regularly review the 
big, often risky innovation projects 
that are expected to provide future 
growth. They do so because of funding 
issues, and some of these projects may 
require extraordinary and long-term 
investments that need board approval. But 
in other industries, boards may be only 
superficially aware of the new products 
3.  Do we regularly review 
and discuss the company’s 
innovation strateg y?
Boards are generally aware of, and 
discuss, the company’s business strategy, 
particularly when it involves important 
investments, mergers and acquisitions, 
and critical geopolitical moves. But 
what about the company’s innovation 
strategy (if it exists and is explicit, which 
is not always the case)? There are indeed 
important decisions that might concern 
the board in a company’s innovation 
choices because of their risk level 
and impact. Think of the adoption of 
innovat ive new business models, 
the creation of totally new product 
categories, or t he conclusion of 
impor ta nt st rateg ic a l l ia nces a nd 
pa rtnerships for the development, 
introduction and distribution of new 
products. Management’s adoption of 
a clear typology of innovation thrusts 
in its board communication would 
def initely faci l it ate such rev iews 
and discussions.1
or services under preparation. Yet, I 
would argue that several projects that 
may be small in terms of investments 
could become ‘game-changers’, and it 
would be wise for the board to review 
them regularly in the presence of R&D 
leaders and innovators. 
surprisingly, only a small minority of 
directors stated that their board had 
adopted these practices. A lot therefore 
remains to be done to ensure that boards 
embrace their innovation governance 
role more proactively.
Here are the ten good-practice questions 
that I would ask:
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CeOs often fall into one of two broad categories: 
fixers and growers.
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Boards usually devote a signif icant 
amount of time to risk assessment and 
reduction. But their focus tends to be on 
financial, environmental, regulatory and 
geopolitical risk. Innovation risk may 
be underestimated, except in the case 
of la rge projects involv ing huge 
investments and new technologies. But 
internal innovation risk is not limited 
to new project a nd tech nolog y 
uncertainties. It can be linked to the loss 
of critical staff, for example. Innovation 
risk can a lso be purely externa l. 
Will competitors introduce a new 
disruptive technolog y that will make 
our products and processes obsolete? 
Will new entrants invade our market 
space through different, more effective 
business models? Will our customers 
expect new solutions that we have not 
thought about? Assessing innovation 
risk is critical to avoid what author 
Ravi Arora calls “pre-science errors”—
underestimating the speed and extent 
of market or technology changes and, 
even worse, “obstinacy errors”—sticking 
to one’s solution too long after markets 
or technologies have changed.2 It is the 
duty of the board to prevent such errors.
4.  Do we regularly review 
and discuss the company’s 
innovation risk?
Boards often exert strong pressure on 
management by setting performance 
goals. But most of these goals tend to 
focus on f inancial performance: top 
and bottom line growth, earnings per 
share, capital utilisation ratios, etc. 
Some companies add other goals to 
focus ma na gement’s at tention on 
worthwhile new objectives, such as 
globa lisation or sustainabilit y. But 
what about innovation if it increasingly 
5.  Do we set specific  
innovation goals for 
management?
Most sustained innovation programmes 
raise many issues. Some of them are 
managerial—how to keep innovators 
motivated and reward them? Others 
are organisational—how to decentralise 
our R&D to tap the brains of our 
international staff ? Many deal with 
intel lectua l propert y (IP)—how do 
we practice open innovation while 
maintaining our IP position? Others 
dea l w ith st rateg ic a l l ia nces a nd 
partnerships—how do we share the 
efforts and risks of new ventures with 
our partners? And there are many more 
issues. 
The question boards should ask is: 
Are we aware of the most acute issues 
that management faces as it steers the 
company’s innovation prog ra mme? 
The board’s mission is of course not to 
interfere a nd become too deeply 
involved in these innovation issues. 
However, its mission is to keep informed 
and help the CEO and top management 
6.  Do we review innovation 
management issues with  
the CEO?
Many companies embarking on a major 
i n nov a t ion boost i n g prog r a m me 
rightfully start with an internal audit 
and, sometimes, a benchmarking exercise 
against best-in-class competitors. Where 
are we deficient in terms of strategy, 
process, resources and tools? Do we 
have the right type of people in R&D 
and marketing, and do we tap their 
creativity effectively? Do we cover all 
types of innovation, ie, not just new 
technologies, products and processes? 
A re our projects well-resourced and 
adequately managed? Are they under 
control? How good is our innovation 
climate? These audits are extremely 
ef fective for highlighting priorit y 
improvement areas, and it is therefore 
good practice for the board to suggest 
that management undertake such audits 
and keep them updated. These audits 
will provide the board with a rich 
perspective on the company’s innovation 
performance issues.
7.  Do we expect management  
to conduct innovation  
audits?
This question is directly related to 
the questions on innovation goals (5) 
and innovation audits (7). Once 
innovation goals have been set and an 
audit conducted, it will be natural for 
the board to follow up and assess 
innovation performa nce. To avoid 
having to delve into too many details, 
innovation performance reviews should 
be carried out once or twice a year 
8.  Do we expect management 
to report on innovation 
performance?
becomes a growth driver? A number 
of highly innovative companies have 
indeed included innovation goals in the 
CEO’s balanced scorecard. One of the 
most commonly found is the percentage 
of sales achieved through new products, 
typically those introduced in the past 
few years. But there are many other 
innovation goals to incite conservative 
management teams to take more risk, for 
example, the percentage of R&D spent 
on high risk/high impact projects. 
Innovation goa ls a re interest ing 
because they actually determine much 
of the company’s long-term financial 
performance. It is therefore good 
practice to discuss these goals with 
the management team and retain the 
most meaningful ones.
Nothing conveys a company’s strong 
innovation orientation better than a 
visit by the entire board to the labs 
and off ices where innovation takes 
place, both locally and abroad. Such 
visits, which are often carried out by 
innovative companies, have a dua l 
advantage. They enable board directors 
to be aware of the real-world issues 
that the company’s innovators face, and 
provide them with a good understanding 
of the risks and rewards of innovation. 
These visits also motivate the frontline 
innovators, who often lack exposure to 
top management. 
9.  Do we know and occasionally 
meet our main corporate 
innovators?
10. Do we take innovation into 
account when appointing  
new leaders?
on the basis of a reasonably limited 
number of innovation performance 
indicators. 
G ood practice ca l ls for these 
indicators to cover several categories. 
A couple of them should be lagging 
indicators, ie, measuring the current 
result of past efforts—the percentage of 
sales achieved through new products 
being one of them. A couple of others 
should be leading indicators, measuring 
the level of efforts done today to 
ensure future innovation performance—
for example, the percentage of the 
R&D budget devoted to high risk/ 
high impact projects mentioned above. 
One or two others should be in the 
category of in-process indicator—the most 
usual measure being the percentage of 
projects managed on schedule and on 
budget. Finally, it is always interesting 
to include a learning indicator to 
measure the reactivity of management 
and its ability to progress on key issues.
This last question is probably the most 
important. The nomination of a new 
CEO is undoubtedly one of the board’s 
most visible and powerful contributions 
to the company. It can herald a new 
and positive era for the company if 
the capabilities of the CEO match the 
company’s strategic imperatives. But it 
ca n sometimes lead to da ma g ing 
regressive moves if the values of the 
new CEO are innovation-unfriendly. 
Management author Robert Tomasko 
notes that CEOs often fall into one of 
t wo broad categories: f i xers a nd 
growers.3 The former are particularly 
appreciated by boa rds when t he 
company needs to be restructured 
and better controlled. But fixers often 
place other va lues a nd priorit ies 
a head of innovation. Growers are 
mor e i nt e r e s t e d i n  i n nov a t ion 
because of its transformational and 
growth characteristics. 
This does not mean that boards 
should a lways prefer growers over 
fixers. There are times when companies 
require drastic performance improvement 
prog ra m mes a nd a n iron-ha nded 
CEO is needed. The board should, 
however, ref lect on the impact the new 
CEO will have on the company’s 
innovation culture and performance. 
This is why it is so important to look 
at the composition of the entire 
management team. How many growers 
does it include and in what position? Will 
these senior leaders be able to counteract 
excessive innovation-unfriendly moves by 
the new fixer CEO?
To conclude, let’s see what Bill 
George, the former CEO and board 
chairman of Medtronic and now a 
professor at Harvard Business School, 
w rote in his foreword to my book 
Innovation Governance, “To be successful, 
companies must be led by leaders—
the CEO, top executives and board of 
directors—who are deeply and irrevocably 
committed to innovation as their path to 
success. Just making innovation one of 
many priorities or passive support for 
innovation are the best ways to ensure 
that their company will never become 
a great innovator.”4 I believe that the 
ten good practices listed above are 
undoubtedly a good way for boards to 
show their real, concrete commitment to 
innovation and its governance.
team reflect on their options. This is why 
it is essential to keep a short open 
agenda item—‘innovation issues’—in 
b oa rd meet i n g s w it h a  sp ec i f ic 
innovation agenda.
